No abstract available
MeSH terms
-
Animals
-
Antigens, Differentiation
-
Antineoplastic Agents / pharmacology*
-
Antineoplastic Agents / therapeutic use
-
Calreticulin / biosynthesis
-
Calreticulin / genetics
-
Calreticulin / physiology*
-
Calreticulin / therapeutic use
-
Cell Cycle Proteins / antagonists & inhibitors
-
Cell Death / immunology
-
Dendritic Cells / immunology
-
Gene Expression Regulation / drug effects
-
Immune System / drug effects*
-
Immune System / radiation effects*
-
Interferon-gamma / physiology
-
Lymphocyte Activation / drug effects
-
Lymphocyte Activation / radiation effects
-
Mice
-
Neoplasm Proteins / antagonists & inhibitors
-
Neoplasms / drug therapy
-
Neoplasms / immunology*
-
Neoplasms / pathology
-
Neoplasms / radiotherapy
-
Neoplasms, Experimental / drug therapy
-
Neoplasms, Experimental / immunology
-
Neoplasms, Experimental / radiotherapy
-
Phagocytosis
-
Phosphoprotein Phosphatases / antagonists & inhibitors
-
Protein Phosphatase 1
-
Rats
-
Recombinant Proteins / therapeutic use
-
T-Lymphocyte Subsets / immunology
Substances
-
Antigens, Differentiation
-
Antineoplastic Agents
-
Calreticulin
-
Cell Cycle Proteins
-
Neoplasm Proteins
-
Recombinant Proteins
-
Interferon-gamma
-
PPP1R15A protein, human
-
Phosphoprotein Phosphatases
-
Ppp1r15a protein, mouse
-
Protein Phosphatase 1